Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein

Immunotherapy for metastatic melanoma offers great promise but, to date, only a subset of patients have responded. There is an urgent need to identify ways of allocating patients to the most beneficial therapy, to increase survival and decrease therapy-associated morbidity and costs. Blood-based bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Buschow, Sonja I., Ramazzotti, Matteo, Reinieren-Beeren, Inge M.J., Heinzerling, Lucie M., Westdorp, Harm, Stefanini, Irene, Beltrame, Luca, Hato, Stanleyson V., Ellebaek, Eva, Gross, Stefanie, Nguyen, Van Anh, Weinlich, Georg, Ragoussis, Jiannis, Baban, Dilair, Schuler-Thurner, Beatrice, Svane, Inge M., Romani, Nikolaus, Austyn, Jonathan M., De Vries, I. Jolanda M., Schuler, Gerold, Cavalieri, Duccio, Figdor, Carl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620184/
https://www.ncbi.nlm.nih.gov/pubmed/28978044
http://dx.doi.org/10.18632/oncotarget.18698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620184/
https://www.ncbi.nlm.nih.gov/pubmed/28978044
http://dx.doi.org/10.18632/oncotarget.18698

Ejemplares similares